Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-02 Option Award | 2026-02-06 6:10 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 1,236,500 | $0 | 1,236,500 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-06 6:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Davis Hugh M. President and COO | 432,400 | $0 | 432,400 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-06 6:06 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Kolbeck Roland Wilhelm Chief Scientific Officer | 430,600 | $0 | 430,600 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-06 6:04 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Hall Jesse Wayne Chief Medical Officer | 441,400 | $0 | 441,400 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-06 6:02 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 439,600 | $0 | 439,600 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-06 6:00 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 445,900 | $0 | 445,900 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-05 4:48 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 20,875 | $0 | 254,885 (Direct) | View |
| 2026-02-03 Tax Withholding | 2026-02-05 4:48 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 5,937 | $3.47 | 254,885 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-05 4:45 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 63,475 | $0 | 1,734,311 (Direct) | View |
| 2026-02-03 Tax Withholding | 2026-02-05 4:45 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 18,611 | $3.47 | 1,734,311 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-05 4:44 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Davis Hugh M. President and COO | 18,675 | $0 | 101,450 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-05 4:41 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 22,025 | $0 | 251,830 (Direct) | View |
| 2026-02-03 Tax Withholding | 2026-02-05 4:41 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 6,449 | $3.47 | 251,830 (Direct) | View |
| 2026-02-01 Tax Withholding(A) | 2026-02-05 4:38 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 10,686 | $3.51 | 214,322 (Direct) | View |
| 2026-02-01 Exercise(A) | 2026-02-05 4:38 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 33,500 | $0 | 214,322 (Direct) | View |
| 2026-02-01 Tax Withholding | 2026-02-03 5:36 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 4,984 | $3.51 | 199,679 (Direct) | View |
| 2026-02-01 Exercise | 2026-02-03 5:36 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 14,750 | $0 | 199,679 (Direct) | View |
| 2025-02-01 Tax Withholding | 2026-02-03 5:34 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 15,980 | $2.48 | 102,773 (Direct) | View |
| 2025-02-01 Tax Withholding(A) | 2026-02-03 5:32 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 15,980 | $2.48 | 102,773 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-05 4:32 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 9,952 | $2.88 | 1,529,056 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-05 4:32 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 29,150 | $0 | 1,529,056 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 33,994 | $3.01 | 173,741 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-05 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 6,171 | $2.88 | 173,741 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 91,900 | $0 | 173,741 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 4:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 22,184 | $3.01 | 181,513 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-05 4:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 4,461 | $2.88 | 181,513 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 4:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 94,450 | $0 | 181,513 (Direct) | View |
| 2025-12-02 Exercise | 2025-12-04 4:50 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Davis Hugh M. President and COO | 26,750 | $0 | 107,000 (Direct) | View |
| 2025-08-01 Option Award | 2025-08-05 4:33 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Kolbeck Roland Wilhelm Chief Scientific Officer | 655,500 | $0 | 655,500 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 4,793 | $0 | 502,345 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 53,930 | $0 | 502,345 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director | 4,793 | $0 | 71,246 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director | 53,930 | $0 | 71,246 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 4,793 | $0 | 768,753 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 53,930 | $0 | 768,753 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 4,793 | $0 | 87,455 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 53,930 | $0 | 87,455 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 4,793 | $0 | 75,684 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 53,930 | $0 | 75,684 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 4,793 | $0 | 111,886 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 53,930 | $0 | 111,886 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 4:32 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Hall Jesse Wayne Chief Medical Officer | 655,500 | $0 | 655,500 (Direct) | View |
| 2025-05-01 Tax Withholding | 2025-05-05 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 2,975 | $1.38 | 1,479,824 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 9,467 | $0 | 1,479,824 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 9,467 | $0 | 1,482,799 (Direct) | View |
| 2025-04-01 Tax Withholding | 2025-04-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 3,042 | $1.48 | 1,482,799 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 3,475 | $0 | 94,983 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 727 | $1.99 | 94,983 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 9,466 | $0 | 1,485,841 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 3,277 | $1.99 | 1,485,841 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 60,925 | $0 | 276,780 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 27,258 | $1.99 | 276,780 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Davis Hugh M. President and COO | 336,300 | $0 | 336,300 (Direct) | View |
| 2025-02-01 Tax Withholding | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 3,559 | $2.48 | 2,631,818 (Direct) | View |
| 2025-02-01 Exercise | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 9,467 | $0 | 2,631,818 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 1,142,700 | $0 | 2,631,818 (Direct) | View |
| 2025-02-01 Tax Withholding | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 11,317 | $2.48 | 668,838 (Direct) | View |
| 2025-02-01 Exercise | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 22,250 | $0 | 668,838 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 377,400 | $0 | 668,838 (Direct) | View |
| 2025-02-01 Tax Withholding | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 5,816 | $2.48 | 530,410 (Direct) | View |
| 2025-02-01 Exercise | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 14,750 | $0 | 530,410 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 396,300 | $0 | 530,410 (Direct) | View |
| 2025-02-01 Tax Withholding | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 15,447 | $2.48 | 549,606 (Direct) | View |
| 2025-02-01 Exercise | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 33,500 | $0 | 549,606 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 375,800 | $0 | 549,606 (Direct) | View |
| 2024-12-31 Tax Withholding | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 41,851 | $0 | 382,959 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 91,130 | $0 | 382,959 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 52,667 | $0 | 382,959 (Direct) | View |
| 2024-12-31 Tax Withholding | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 38,221 | $2.48 | 236,476 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 94,450 | $0 | 236,476 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 40,000 | $0 | 236,476 (Direct) | View |